Search
for
Sort by
Research 61–90 of 1000+
- Transversely Sectioned Mini-Punch Grafting: A Novel Technique for Effective Treatment of Hairline Vitiligo
- Pathophysiology of vitiligo
- Hair regrowth in alopecia areata and re‐pigmentation in vitiligo in response to treatment: Commonalities and differences
- Genetics of Vitiligo: A Review
- Phototherapy with Topical Minoxidil in Vitiligo: A Randomized Control Trial
- Unraveling Vitiligo: From Immune Mechanisms to Promising Therapeutic Strategies
- Co-occurrence of Progressive Hemifacial atrophy due to Morphea with homolateral segmental Vitiligo: a case report
- Treatment of Vitiligo Associated Eyebrow and Eyelash Leukotrichia - A Systematic Review of Existing Information
- Regulating the Wnt/β-catenin Signaling Pathway Promotes Repigmentation in Vitiligo Using Fire Needle Therapy
- Surgical Approaches for Repigmenting Vitiligo 2.0
- DataSheet1_Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention.PDF
- Silymarin in combination with hair follicle transplantation as a potential treatment for refractory vitiligo: A double‐blind randomized controlled trial
- Vitiligo and alopecia areata: apples and oranges?
- Skin 3D Bioprinting. Applications in Cosmetology
- Co‐regulatory mechanisms and potential markers of oxidative stress‐related genes in vitiligo and alopecia areata
- Engineering a New Mouse Model for Vitiligo
- Drug-induced vitiligo: a real-world pharmacovigilance analysis of the FAERS database
- LB1056 Phase 1b: Translational evaluation of VYN201, a pan-BD BET inhibitor, for the treatment of non-segmental vitiligo
- A New Assessment Method of Vitiligo by Combination of Dermoscopy and Reflectance Confocal Microscopy
- The Complex connection between Vitiligo and Lupus: Exploring the Link
- TREATMENT OF INDRALUPTA THROUGH AYURVED-A CASE STUDY
- Vitiligo - Part 2 - classification, histopathology and treatment
- Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention
- Regenerative Medicine-Based Treatment for Vitiligo: An Overview
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- Vitiligo—Current Treatment Options and Future Perspectives
- Serum Granulysin Levels in Vitiligo and Alopecia Areata: A Potential Biomarker for Disease Activity and Dermoscopic Evaluation
- Vitiligo
- Tofacitinib: The selected selective JAK inhibitor in paediatric dermatology
- Transverse Needling After Autologous Mini-Punch Grafts Improves Repigmentation in Stable Non-Segmental Vitiligo